CN Stock MarketDetailed Quotes

301089 Tuoxin Pharmaceutical Group

Watchlist
  • 29.12
  • -0.35-1.19%
Market Closed Sep 2 15:00 CST
3.68BMarket Cap-54025P/E (TTM)

Tuoxin Pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-66.70%218.76M
-80.34%108.32M
6.47%835.51M
76.42%746.13M
166.36%656.98M
325.33%551.01M
56.17%784.72M
8.88%422.92M
-13.16%246.65M
-10.22%129.55M
Operating revenue
-66.70%218.76M
-80.34%108.32M
6.47%835.51M
76.42%746.13M
166.36%656.98M
325.33%551.01M
56.17%784.72M
8.88%422.92M
-13.16%246.65M
-10.22%129.55M
Other operating revenue
--0
----
-48.96%3.53M
----
-14.88%4.57M
----
211.47%6.91M
----
157.78%5.37M
----
Total operating cost
-9.89%230.77M
-23.19%111.6M
10.64%517.16M
16.54%366.45M
26.10%256.09M
46.58%145.29M
9.98%467.41M
0.95%314.43M
-7.21%203.09M
-8.21%99.12M
Operating cost
2.23%165.05M
-15.92%79.99M
12.45%351.95M
-1.45%225.74M
9.51%161.45M
31.34%95.13M
0.33%313M
-3.10%229.07M
-12.75%147.42M
-13.81%72.43M
Operating tax surcharges
-69.36%2.98M
-83.16%1.28M
10.65%13.02M
106.30%11.27M
159.76%9.74M
390.38%7.58M
73.40%11.77M
13.93%5.47M
7.11%3.75M
-5.09%1.55M
Operating expense
2.73%6.03M
-19.39%2.1M
9.64%9.83M
67.92%8.99M
63.34%5.87M
32.63%2.61M
30.63%8.96M
6.27%5.35M
14.00%3.59M
-19.68%1.97M
Administration expense
-27.50%42.92M
-40.31%20.72M
-10.51%94.47M
50.28%88.22M
58.33%59.21M
90.76%34.72M
51.13%105.57M
34.31%58.71M
34.67%37.4M
44.72%18.2M
Financial expense
-13.55%-2.39M
-253.08%-728.9K
-15.56%-3.36M
14.74%-2.72M
13.20%-2.1M
59.42%-206.44K
-134.06%-2.91M
-141.62%-3.19M
-144.23%-2.42M
-118.94%-508.7K
-Interest expense (Financial expense)
----
-99.78%620.52
-90.04%337.07K
-88.10%285.06K
-86.60%238.68K
-68.10%285.06K
-62.92%3.38M
-68.82%2.4M
-65.81%1.78M
-66.76%893.68K
-Interest Income (Financial expense)
-3.56%-1.82M
49.53%-487.28K
34.53%-3.29M
72.56%-965.43K
36.21%-1.76M
41.75%-965.43K
-109.39%-5.02M
-244.65%-3.52M
-292.88%-2.75M
-521.60%-1.66M
Research and development
-26.28%16.17M
50.92%8.25M
65.22%51.25M
83.58%34.94M
64.22%21.93M
-0.49%5.46M
47.91%31.02M
36.90%19.03M
33.65%13.36M
19.00%5.49M
Credit Impairment Loss
130.07%2.42M
127.82%2.39M
-188.41%-4.49M
-239.36%-7.01M
-315.14%-8.04M
-966.55%-8.58M
322.78%5.07M
803.52%5.03M
389.28%3.74M
255.10%989.67K
Asset Impairment Loss
----
----
-12.00%-10.77M
-1,249.42%-4.15M
-1,107.76%-3.64M
----
-820.89%-9.61M
284.90%361.05K
120.44%361.05K
----
Other net revenue
432.69%10.86M
227.33%5.76M
-72.15%3.34M
-89.06%2.22M
-124.31%-3.27M
-189.04%-4.52M
587.24%11.98M
940.58%20.25M
1,519.74%13.43M
1,295.65%5.08M
Fair value change income
-156.21%-544.78K
-345.84%-705K
245.84%546.87K
-110.00%-158.13K
-11.75%969.16K
---158.13K
-74.49%158.13K
--1.58M
--1.1M
----
Invest income
-44.38%1.95M
5.33%1.45M
16.97%6.57M
78.07%6.29M
52.45%3.51M
8.74%1.38M
60,036.24%5.62M
42,673.26%3.53M
32,793.54%2.3M
30,963.23%1.27M
-Including: Investment income associates
----
----
-339.15%-115.51
----
----
----
-99.48%48.3
-100.09%-7.73
-100.11%-7.73
-97.12%117.54
Asset deal income
----
---4.91K
----
----
----
----
--28.07K
----
----
----
Other revenue
78.71%7.03M
-7.12%2.63M
7.03%11.47M
-25.64%7.25M
-33.60%3.94M
0.36%2.83M
141.71%10.72M
242.19%9.75M
181.53%5.93M
76.77%2.82M
Operating profit
-100.29%-1.15M
-99.38%2.48M
-2.31%321.68M
196.64%381.9M
597.74%397.62M
1,029.85%401.19M
315.54%329.29M
63.19%128.74M
-11.26%56.99M
-3.19%35.51M
Add:Non operating Income
19,562.18%83.16K
49,829.20%29.96K
-84.31%1.42K
--1.42K
--422.96
--60
235.80%9.07K
----
----
----
Less:Non operating expense
-86.85%267.75K
-96.76%54.63K
27.81%5.15M
91.79%2.28M
135.91%2.04M
298.61%1.69M
234.31%4.03M
314.23%1.19M
209.05%863.05K
4,760.97%423.17K
Total profit
-100.34%-1.33M
-99.39%2.45M
-2.69%316.53M
197.62%379.62M
604.85%395.58M
1,038.67%399.5M
316.79%325.27M
62.26%127.55M
-12.22%56.12M
-4.32%35.09M
Less:Income tax cost
-99.48%446.07K
-99.60%383.82K
89.65%73.46M
267.70%66.42M
4,063.55%86.05M
1,332.44%95.2M
214.14%38.73M
42.01%18.06M
-80.49%2.07M
1.40%6.65M
Net profit
SL-1.78M
-99.32%2.07M
-15.17%243.07M
186.06%313.19M
472.61%309.53M
970.02%304.31M
336.05%286.54M
66.17%109.48M
1.34%54.06M
-5.57%28.44M
Net profit from continuing operation
-100.57%-1.78M
-99.32%2.07M
-15.17%243.07M
186.06%313.19M
472.61%309.53M
970.02%304.31M
336.05%286.54M
66.17%109.48M
1.34%54.06M
-5.57%28.44M
Net profit of parent company owners
-100.57%-1.78M
-99.32%2.07M
-15.17%243.07M
186.06%313.19M
472.61%309.53M
970.02%304.31M
336.05%286.54M
66.17%109.48M
1.34%54.06M
-5.57%28.44M
Earning per share
Basic earning per share
-100.41%-0.01
-99.17%0.02
-14.98%1.93
186.21%2.49
472.09%2.46
952.17%2.42
243.94%2.27
24.29%0.87
-23.21%0.43
-28.13%0.23
Diluted earning per share
-100.41%-0.01
-99.17%0.02
-14.98%1.93
186.21%2.49
472.09%2.46
952.17%2.42
243.94%2.27
24.29%0.87
-23.21%0.43
-28.13%0.23
Other composite income
-26.56%-2.13M
32.79%-1.68M
-290.64%-332.05K
-290.64%-332.05K
Other composite income of parent company owners
----
----
-26.56%-2.13M
----
----
----
32.79%-1.68M
-290.64%-332.05K
-290.64%-332.05K
----
Total composite income
-100.57%-1.78M
-99.32%2.07M
-15.41%240.95M
186.93%313.19M
476.15%309.53M
970.02%304.31M
350.64%284.86M
65.23%109.15M
0.39%53.72M
-7.07%28.44M
Total composite income of parent company owners
-100.57%-1.78M
-99.32%2.07M
-15.41%240.95M
186.93%313.19M
476.15%309.53M
970.02%304.31M
350.64%284.86M
65.23%109.15M
0.39%53.72M
-7.07%28.44M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -66.70%218.76M-80.34%108.32M6.47%835.51M76.42%746.13M166.36%656.98M325.33%551.01M56.17%784.72M8.88%422.92M-13.16%246.65M-10.22%129.55M
Operating revenue -66.70%218.76M-80.34%108.32M6.47%835.51M76.42%746.13M166.36%656.98M325.33%551.01M56.17%784.72M8.88%422.92M-13.16%246.65M-10.22%129.55M
Other operating revenue --0-----48.96%3.53M-----14.88%4.57M----211.47%6.91M----157.78%5.37M----
Total operating cost -9.89%230.77M-23.19%111.6M10.64%517.16M16.54%366.45M26.10%256.09M46.58%145.29M9.98%467.41M0.95%314.43M-7.21%203.09M-8.21%99.12M
Operating cost 2.23%165.05M-15.92%79.99M12.45%351.95M-1.45%225.74M9.51%161.45M31.34%95.13M0.33%313M-3.10%229.07M-12.75%147.42M-13.81%72.43M
Operating tax surcharges -69.36%2.98M-83.16%1.28M10.65%13.02M106.30%11.27M159.76%9.74M390.38%7.58M73.40%11.77M13.93%5.47M7.11%3.75M-5.09%1.55M
Operating expense 2.73%6.03M-19.39%2.1M9.64%9.83M67.92%8.99M63.34%5.87M32.63%2.61M30.63%8.96M6.27%5.35M14.00%3.59M-19.68%1.97M
Administration expense -27.50%42.92M-40.31%20.72M-10.51%94.47M50.28%88.22M58.33%59.21M90.76%34.72M51.13%105.57M34.31%58.71M34.67%37.4M44.72%18.2M
Financial expense -13.55%-2.39M-253.08%-728.9K-15.56%-3.36M14.74%-2.72M13.20%-2.1M59.42%-206.44K-134.06%-2.91M-141.62%-3.19M-144.23%-2.42M-118.94%-508.7K
-Interest expense (Financial expense) -----99.78%620.52-90.04%337.07K-88.10%285.06K-86.60%238.68K-68.10%285.06K-62.92%3.38M-68.82%2.4M-65.81%1.78M-66.76%893.68K
-Interest Income (Financial expense) -3.56%-1.82M49.53%-487.28K34.53%-3.29M72.56%-965.43K36.21%-1.76M41.75%-965.43K-109.39%-5.02M-244.65%-3.52M-292.88%-2.75M-521.60%-1.66M
Research and development -26.28%16.17M50.92%8.25M65.22%51.25M83.58%34.94M64.22%21.93M-0.49%5.46M47.91%31.02M36.90%19.03M33.65%13.36M19.00%5.49M
Credit Impairment Loss 130.07%2.42M127.82%2.39M-188.41%-4.49M-239.36%-7.01M-315.14%-8.04M-966.55%-8.58M322.78%5.07M803.52%5.03M389.28%3.74M255.10%989.67K
Asset Impairment Loss ---------12.00%-10.77M-1,249.42%-4.15M-1,107.76%-3.64M-----820.89%-9.61M284.90%361.05K120.44%361.05K----
Other net revenue 432.69%10.86M227.33%5.76M-72.15%3.34M-89.06%2.22M-124.31%-3.27M-189.04%-4.52M587.24%11.98M940.58%20.25M1,519.74%13.43M1,295.65%5.08M
Fair value change income -156.21%-544.78K-345.84%-705K245.84%546.87K-110.00%-158.13K-11.75%969.16K---158.13K-74.49%158.13K--1.58M--1.1M----
Invest income -44.38%1.95M5.33%1.45M16.97%6.57M78.07%6.29M52.45%3.51M8.74%1.38M60,036.24%5.62M42,673.26%3.53M32,793.54%2.3M30,963.23%1.27M
-Including: Investment income associates ---------339.15%-115.51-------------99.48%48.3-100.09%-7.73-100.11%-7.73-97.12%117.54
Asset deal income -------4.91K------------------28.07K------------
Other revenue 78.71%7.03M-7.12%2.63M7.03%11.47M-25.64%7.25M-33.60%3.94M0.36%2.83M141.71%10.72M242.19%9.75M181.53%5.93M76.77%2.82M
Operating profit -100.29%-1.15M-99.38%2.48M-2.31%321.68M196.64%381.9M597.74%397.62M1,029.85%401.19M315.54%329.29M63.19%128.74M-11.26%56.99M-3.19%35.51M
Add:Non operating Income 19,562.18%83.16K49,829.20%29.96K-84.31%1.42K--1.42K--422.96--60235.80%9.07K------------
Less:Non operating expense -86.85%267.75K-96.76%54.63K27.81%5.15M91.79%2.28M135.91%2.04M298.61%1.69M234.31%4.03M314.23%1.19M209.05%863.05K4,760.97%423.17K
Total profit -100.34%-1.33M-99.39%2.45M-2.69%316.53M197.62%379.62M604.85%395.58M1,038.67%399.5M316.79%325.27M62.26%127.55M-12.22%56.12M-4.32%35.09M
Less:Income tax cost -99.48%446.07K-99.60%383.82K89.65%73.46M267.70%66.42M4,063.55%86.05M1,332.44%95.2M214.14%38.73M42.01%18.06M-80.49%2.07M1.40%6.65M
Net profit SL-1.78M-99.32%2.07M-15.17%243.07M186.06%313.19M472.61%309.53M970.02%304.31M336.05%286.54M66.17%109.48M1.34%54.06M-5.57%28.44M
Net profit from continuing operation -100.57%-1.78M-99.32%2.07M-15.17%243.07M186.06%313.19M472.61%309.53M970.02%304.31M336.05%286.54M66.17%109.48M1.34%54.06M-5.57%28.44M
Net profit of parent company owners -100.57%-1.78M-99.32%2.07M-15.17%243.07M186.06%313.19M472.61%309.53M970.02%304.31M336.05%286.54M66.17%109.48M1.34%54.06M-5.57%28.44M
Earning per share
Basic earning per share -100.41%-0.01-99.17%0.02-14.98%1.93186.21%2.49472.09%2.46952.17%2.42243.94%2.2724.29%0.87-23.21%0.43-28.13%0.23
Diluted earning per share -100.41%-0.01-99.17%0.02-14.98%1.93186.21%2.49472.09%2.46952.17%2.42243.94%2.2724.29%0.87-23.21%0.43-28.13%0.23
Other composite income -26.56%-2.13M32.79%-1.68M-290.64%-332.05K-290.64%-332.05K
Other composite income of parent company owners ---------26.56%-2.13M------------32.79%-1.68M-290.64%-332.05K-290.64%-332.05K----
Total composite income -100.57%-1.78M-99.32%2.07M-15.41%240.95M186.93%313.19M476.15%309.53M970.02%304.31M350.64%284.86M65.23%109.15M0.39%53.72M-7.07%28.44M
Total composite income of parent company owners -100.57%-1.78M-99.32%2.07M-15.41%240.95M186.93%313.19M476.15%309.53M970.02%304.31M350.64%284.86M65.23%109.15M0.39%53.72M-7.07%28.44M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg